A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Science & Tech
Abrams tank, HIMARS rocket launchers on display as Taipei defense expo opens
09/18/2025 03:18 PM - Business
Taiwan shares close up 1.30%
09/18/2025 01:50 PM - Business
Nomura launches cross-border ETF listings in Taiwan, Japan
09/18/2025 01:45 PM - Society
Botulism, collisions top threats to migratory birds in Taiwan: MOA
09/18/2025 01:17 PM - Politics
Taiwan's newest Sky Bow missile system enters mass production: NCSIST
09/18/2025 01:08 PM